Home › Pharmaceuticals › Therapeutic/drugs
Therapeutic/drugs Market Research Report
The drug manufacturers are suffering due to raising costs attributed to increasing complexities in clinical trials. Hence speedy adoption of new technologies is very essential for market players to optimize their costs and to have a competitive edge in the market. Innovation in breakthrough technologies has widened the market scope for therapeutics and drugs market. There has been signification shift in focus from providing general drugs and therapy to providing drugs for target cluster and personalized therapies. This is attributed to market transition from pharmaceutical to biotechnology. Enhancing technologies impacting high growth markets such as proteomics, genomics, and personalized medicines have led a long way in introducing effective drugs and therapies. Increasing regulations imposed on drug development process have created a demand for automated tools such as bioinformatics that can store analytical data and facilitate the researcher to design and develop effective drugs. Entry of generic drugs that are less expensive has posed threat to the market players in the drugs market. Increasing safety requirement and legislation is furthermore adding pressure on the drug and therapy providers to increase efficiency. Enhancing Drug development technologies and emerging concepts in life sciences have a greater role in such complicated environment.
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Global Weight Loss and Diet Management Market (2009 - 2014)Obesity and weight gain issues have always been a major concern impacting the health and fitness of the individuals. Increasing awareness levels among the appearance and calorie conscious consumers has opened up new avenues and opportunities to this market. The rate of new product entry in the weight management segment is significantly high, necessitating industry participants to adopt proactive strategies and keep ahead of competition. |
July 2009 | $ 4650 |
|
Autoimmune Treatment Market (2009 - 2014)The report sizes the market for the diagnosis and therapeutic technologies for the auto immune diseases. It also tracks the advances in the technologies along with the profiles and strategies of the key players in this market. The report highlights the new approaches being pursued in this market. |
September 2009 | $ 4650 |
|
BRIC Diabetes Drugs Market (2010-2015) in Brazil, Russia, India, ChinaThe prevalence of diabetes is increasing globally with the increase in life expectancy and rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated over 20 million patients in the region requiring diabetes treatment by 2025. India and China have the highest number of diabetics in the world – China alone is expected to have more than 71 million diabetic patients by 2025; and the similarly huge patient-base in India has already attracted a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come. |
April 2010 | $ 4650 |
|
Global Oncology Pharmaceuticals & Therapeutics MarketEach section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 40 company profiles. |
October 2010 | $ 4650 |
|
Top 25 OTC Drugs Market (2010 - 2015)Over the counter drugs can be broadly segmented as analgesics, topical medicines, cough and cold preparations, indigestion preparations, medicated skin products, first aid kits, plaster and bandages, traditional medicines and vitamins and minerals. Among all the OTC drugs cough and cold preparations lead the OTC healthcare market with almost 18% of market share. Johnson& Johnson, GlaxoSmithKline Plc and Novartis AG are the leading players of global OTC market. |
October 2010 | $ 4650 | |
Monoclonal Antibodies Market (2010 - 2015)The global market for diagnostic and therapeutic market is expected to exceed $ 25 million market by the end of 2010. mAbs held the top 3 ranks among the top selling brands in 2008. Monoclonal antibodies present significant opportunities as they are targeted therapy (They impact only the diseased cells and do not harm healthy cells) unlike chemotherapy drugs. |
October 2010 | $ 4650 | |
Cardiovascular Therapy - Advanced Technologies And Global Market (2009 - 2014)The research report outlines the latest developments in the cardiovascular therapy industry across the globe. The market data includes innovative technologies, key players, market trends and opportunities, drivers and challenges are clearly identified and examined. |
October 2010 | $ 4650 | |
Anti Nicotine Therapies (2010 - 2015)Smoking cessation products are gaining popularity in both OTC and prescription products market segments. Increasing burden on healthcare system due to deteriorating quality of life because of smoking and several side effects associated with the current smoking cessation marketed products, builds up the need of novel products with better efficacy in this market. |
October 2010 | $ 4650 |
Custom Research
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/custom-research.asp to specify your custom Research Requirement
Search reports
